Sales Contact

T: +33 1 8362 9036

Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview


> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [1150 EMAT Reports], which includes:


Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.


The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.


The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.


Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
08/05/2024 Unigloves (Singapore) Pte Unigloves Arzt- & Klinikbedarf Handelsgesellschaft Germany Specialised R&W, Medical Supplies * 116887
27/03/2024 Private group led by Carvest, Siparex Capron Podologie Saône-Et-Loire Medical Supplies * 116883
13/03/2024 Advanced Medical Solutions Group Peters Surgical Hauts-De-Seine Medical Supplies *** 116034
04/03/2024 Halma Rovers Medical Devices Netherlands Medical Equipment ** 115901
07/02/2024 Private group led by Exponent Private Equity Chanelle Pharma Ireland Pharmaceuticals, Veterinary Pharmaceuticals ** 116340
04/01/2024 L'Occitane International Dr. Vranjes Firenze Italy Personal Products, Cosmetics & Perfumes ** 115896
29/11/2023 Stille Fehling Instruments Germany Medical Equipment *** 114894
10/10/2023 Hamilton Thorne Gynetics Belgium Medical Equipment *** 114949
25/09/2023 Enovis Limacorporate Italy Medical Implants or Prostheses Manufacturers *** 115277
31/07/2023 Mindray Medical Netherlands DiaSys Diagnostic Systems Germany Diagnostic Medical Equipment * 113498
28/07/2023 Elos Medtech Klingel Germany Medical Equipment, Machining Operations ** 115184
18/07/2023 Groupe Vabel Laboratoires Sarbec Nord Personal Products * 113988
03/07/2023 Novacyt Yourgene Health United Kingdom Medical Diagnostic Laboratory ** 116303
29/06/2023 Donaldson Univercells Technologies Belgium Industrial Machinery, Medical Equipment *** 113582
16/05/2023 Shandong Sinocera Functional Material Co DEKEMA Dental-Keramikoefen Germany Medical Equipment *** 112784
28/04/2023 PI Industries Archimica Italy Pharmaceuticals, Laboratory Testing Services ** 112912
24/04/2023 Private Group backed by Vivalto Partners Laboratoires Delbert France Pharmaceuticals, Biomedical Research Laboratory * 112600
19/04/2023 Koninklijke DSM Adare Pharmaceuticals (Adare Biome) Yvelines Pharmaceuticals *** 112493
03/04/2023 Enovis Novastep Ille-Et-Vilaine Medical Equipment ** 115262
03/04/2023 Sonic Healthcare Diagnosticum MVZ Diagnosticum Germany Medical Diagnostic Laboratory ** 116268
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report